KBC Group’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30K Hold
2,555
﹤0.01% 1797
2025
Q4
$39K Hold
2,555
﹤0.01% 1693
2025
Q3
$55K Hold
2,555
﹤0.01% 1613
2025
Q2
$57K Sell
2,555
-1,407
-36% -$31.3K ﹤0.01% 1549
2025
Q1
$94K Hold
3,962
﹤0.01% 1514
2024
Q4
$84K Buy
3,962
+1,577
+66% +$41.4K ﹤0.01% 1661
2024
Q3
$77K Buy
2,385
+576
+32% +$17K ﹤0.01% 1462
2024
Q2
$43K Buy
1,809
+216
+14% +$5.54K ﹤0.01% 1706
2024
Q1
$48K Hold
1,593
﹤0.01% 1584
2023
Q4
$51K Hold
1,593
﹤0.01% 1513
2023
Q3
$47K Buy
+1,593
New +$57.3K ﹤0.01% 1499

Other funds holding SGRY

KBC Group's SGRY Position: Q1 2026 in Review

KBC Group held its Surgery Partners (SGRY) position steady in Q1 2026 at 2,555 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

KBC Group first reported a position in SGRY in Q3 2023 and has held it in 11 quarters since. The position peaked at $94K in Q1 2025. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • KBC Group held 2,555 shares of Surgery Partners worth $30K as of Q1 2026.
  • KBC Group left its Surgery Partners share count unchanged in Q1 2026.
  • Surgery Partners made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1797 holding.
  • KBC Group first reported a position in Surgery Partners in Q3 2023 and has held it in 11 quarters since.
  • KBC Group's Surgery Partners position peaked at $94K in Q1 2025.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.